Idraparinux versus standard therapy for venous thromboembolic disease. N Engl J Med. 2007;1094-1104

Abstract

Get full access to this article

View all access options for this article.

References

Eriksson BI , Dahl OE , Rosencher N. , et al; RE-NOVATE Study Group. Dabigatrin etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomized double-blind, non-inferiority trial . Lancet. 2007;370:949-956.

Amadeus Investigators , Bousser MG , Bouthier J. , Buller HR , et al. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomized, open-label, non inferiority trial. Lancet. 2008371:315-321.

Hirsh J. , O'Donnell M. , Eikelboom JW Beyond unfractionated heparin and warfarin: current and future advances. Circulation. 2007;116:552-560.